ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[머니투데이] 큐로셀 “안발셀, 킴리아 넘는 차세대 CAR-T 치료제 자신”
2024/06/10
큐로셀 “안발셀, 킴리아 넘는 차세대 CAR-T 치료제 자신” (naver.com)
Prev
[청년의사][바이오USA 2024] 큐로셀 “해외 법인 설립 검토”
Next
[더벨] 분명한 강점과 한계, 그럼에도 국산 CAR-T가 필요한 이유
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.